{"article_title": "Q&A With Jim Januzzi From Massachusetts General Hospital", "article_keywords": ["heart", "work", "ways", "hospital", "jim", "januzzi", "general", "qa", "failure", "massachusetts", "worsening"], "article_url": "http://www.hcplive.com/medical-news/qa-with-jim-januzzi-from-massachusetts-general-hospital-using-biomarkers-to-learn-more-about-heart-failure", "article_text": "Q&A With Jim Januzzi From Massachusetts General Hospital: Using Biomarkers To Learn More About Heart Failure\n\nTreating heart failure can be a delicate practice for doctors depending on the severity of the condition. Finding new ways to help these patients is moving from the clinical side of medicine into the laboratory to find more exacting treatment methods.James (Jim) Januzzi, MD, from Massachusetts General Hospital discussed work being done in this field during the American Heart Association's Annual Scientific Sessions in Orlando.Patients with chronic heart failure may not always be at risk of a fatal cardiac event but there has not been a clear diagnosis of what worsening heart failure means. Researchers are looking to find more definitive answers for these and other questions.", "article_metadata": {"description": "Treating heart failure can be a delicate practice for doctors depending on the severity of the condition. Finding new ways to help these patients is moving from the clinical side of medicine into the laboratory to find more exacting treatment methods.", "og": {"site_name": "MD Magazine", "description": "Treating heart failure can be a delicate practice for doctors depending on the severity of the condition. Finding new ways to help these patients is moving from the clinical side of medicine into the laboratory to find more exacting treatment methods.", "title": "Q&A With Jim Januzzi From Massachusetts General Hospital: Using Biomarkers To Learn More About Heart Failure", "url": "http://www.hcplive.com/medical-news/qa-with-jim-januzzi-from-massachusetts-general-hospital-using-biomarkers-to-learn-more-about-heart-failure", "image": "https://s3.amazonaws.com/hcplive/v1_media/_upload_image/_thumbnails/Screen Shot 2015-12-28 at 12.17.53 PM.png", "type": "Article"}, "msapplication-TileColor": "#ffffff", "msapplication-TileImage": "https://s3.amazonaws.com/hcplive/v2_media/_core/favi/ms-icon-144x144.png", "keywords": "heart failure, cardiology, pharmacy, surgery, hospital medicine", "theme-color": "#ffffff"}, "article_summary": "Q&A With Jim Januzzi From Massachusetts General Hospital: Using Biomarkers To Learn More About Heart FailureTreating heart failure can be a delicate practice for doctors depending on the severity of the condition.\nResearchers are looking to find more definitive answers for these and other questions.\nFinding new ways to help these patients is moving from the clinical side of medicine into the laboratory to find more exacting treatment methods.James (Jim) Januzzi, MD, from Massachusetts General Hospital discussed work being done in this field during the American Heart Association's Annual Scientific Sessions in Orlando.Patients with chronic heart failure may not always be at risk of a fatal cardiac event but there has not been a clear diagnosis of what worsening heart failure means."}